Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: A community-based clinical trial

Obstetrics and Gynecology

Volumn 90, Issue 3, 1997, Pages 421-427

  Wertlake, Paul T ^a,b   Francus, Kenneth ^a,b   Newkirk, Gary R ^a,b   Parham, Groesbeck P ^c  

^a UniLab   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHEMOLUMINESCENCE; COLPOSCOPY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASS SCREENING; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; COLPOSCOPY; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; VAGINAL SMEARS;

EID: 0030788434     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00288-3     Document Type: Article

References (41)

1. Cancer facts and figures 1988. New York: American Cancer Society, 1988:10.
2. Silverberg E, Lubeta JA. Cancer Statistics. 1989;39:3.
3. Cancer facts & figures - 1993. Atlanta: American Cancer Society, 1993:7.
4. Creasman WT, Clarke-Pearson DL, Ashe C, Weed JC Jr. The abnormal Pap smear - what to do next? Cancer. 48:1981;515-522.
5. Benedet JL, Anderson GH, Matisic JP. Cervical cancer detection A comprehensive program for cervical cancer detection and management . Am J Obstet Gynecol. 166:1992;1254-1259.
6. Davis GL, Hernandez E, Davis JL, Miyazawa K. Atypical squamous cells in Papanicolaou smears. Obstet Gynecol. 69:1987;43-46.
7. Stafl A. Cervicography in cervical cancer detection. Postgraduate Obstet Gynecol. 10:1990;2-7.
8. Morell ND, Taylor JR, Snyder RN, Ziel HK, Saltz A, Willie S. False-negative cytology rates in patients in whom invasive cervical cancer subsequently developed. Obstet Gynecol. 60:1982;41-45.
9. Sherman ME, Kelly D. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears Screening failures or rapid progression? Mod Pathol. 5:1992;337-342.
10. The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 Bethesda workshop. J Reprod Med 1992;37:383-5.
11. Hutchinson ML, Agarwal P, Denault T. A new look at cervical cytology Thin Prep Multicenter Trial results . Acta Cytol. 36:1992;499-504.
12. Koss LG. The Papanicolaou test for cervical cancer detection A triumph and a tragedy . JAMA. 261:1989;737-743.
13. Smedts F, Ramaekers FC, Vooijs PG. The dynamics of keratin expression in malignant transformation of cervical epithelium A review . Obstet Gynecol. 82:1993;465-474.
14. Eddy DM. Screening for cervical cancer. Ann Intern Med. 113:1990;214-226.
15. Stafl A. Cervicography A new method for screening for cervical cancer detection . Am J Obstet Gynecol. 139:1981;815-825.
16. August N. Cervicography for evaluating the "atypical" Papanicolaou smear. J Reprod Med. 36:1991;89-94.
17. Tawa K, Forsythe A, Cove JK, Saltz A, Peters HW, Watring WG. A comparison of the Papanicolaou smear and the cervigram, sensitivity, specificity and cost analysis. Obstet Gynecol. 71:1988;229-235.
18. Tidy J, Mason W, Farrell P. A new and sensitive method for screening for human papillomavirus infection. Obstet Gynecol. 74:1989;410-413.
19. Ritter DB, Kadish AS, Vermund SH, Romney SL, Villari D, Burk RD. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervico-vaginal cells as a predictor of cervical neoplasia in a high-risk population. Am J Obstet Gynecol. 159:1988;1517-1525.
20. Bauer HM, Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 265:1991;472-477.
21. Lonky NM, Edwards G. Comparison of chemiluminescent light versus incandescent light in the visualization of acetowhite epithelium. Am J Gyn Health. 6:1992;6-10.
22. Massad LS, Lonky NM, Mutch DG, Mann WJ, Blanco JS, Vasilev SA, et al. The use of speculoscopy in the evaluation of women with atypical Papanicolaou smears Improved cost effectiveness by selective colposcopy . J Reprod Med. 38:1993;163-169.
23. Mann W, Lonky N, Massad S, Scotti R, Blanco J, Vasilev S. Papanicolaou smear screening augmented by a magnified chemiluminescent exam. Int J Gynaecol Obstet. 43:1993;289-296.
24. Lonky NM, Mann WJ, Massad LS, Mutch DG, Blanco JS, Vasilev SA, et al. Ability of visual tests to predict underlying cervical neoplasia. J Reprod Med. 40:1995;530-536.
25. Davey DD, Nielson ML, Naryshkin S, Rob JA, Cohen T, Kline TS. Atypical squamous cells of undetermined significance. Arch Pathol Lab Med. 120:1996;440-444.
26. Polatti F, Giunta P, Migliora P, Comerci V, Volpi M, Pampuri R. Speculoscopy combined with Pap smear in the cervico-vaginal screening. Curr Ob Gyn Italian ed. 3:1994;178-180.
27. Navarre G. Screening with colposcopy in a prepaid health center. Obstet Gynecol Surv. 40:1985;185-189.
28. Szarewski A, Cuzick J, Edwards R, Butler B, Singer A. The use of cervicography in a primary screening service. Br J Obstet Gynaecol. 98:1991;313-317.
29. Moss TR, Hawkswell J, Fogarty B, Dadswell C. The value of primary colposcopy in genitourinary medicine - a six year review. Genitourin Med. 70:1994;191-195.
30. Spitzer M, Krumholz BA, Chernys AE, Seltzer V, Lightman AR. Comparative utility of repeat Papanicolaou smears, cervicography and colposcopy in the evaluation of atypical Papanicolaou smears. Obstet Gynecol. 69:1987;731-735.
31. Jones DED, Creasman WT, Dombroski RA, Lentz SS, Waeltz JL. Evaluation of the atypical Pap smear. Am J Obstet Gynecol. 157:1987;544-549.
32. Reiter R. Management of initial atypical cervical cytology A randomized prospective study . Obstet Gynecol. 68:1986;237-240.
33. Morrison BW, Erickson ER, Doshi N, Russo JF. The significance of atypical cervical smears. J Reprod Med. 33:1988;809-812.
34. Schiffman MH, Kurman R, Barnes W, Lancaster W. HPV infection and early cervical cytologic abnormalities in 3175 Washington D.C. women. Howley PM, Broker TP. Papillomaviruses. 1990;81-88 Wiley-Liss, New York.
35. Negrini BP, Schiffman MH, Kurman RJ, Barnes W, Lannom L, Malley K, et al. Oral contraception use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res. 50:1990;4670-4675.
36. Busseniers AE, Sidawy MK. Inflammatory atypia on cervical smears A diagnostic dilemma for the gynecologist . J Reprod Med. 36:1991;85-88.
37. Borst M, Butterworth CE, Baker V. Human papillomavirus screening for women with atypical Papanicolaou smears. J Reprod Med. 36:1991;95-99.
38. Parham GP, Shaver M, Brown P, Zumwalt T, Salem F, Savage E. Significance of a first-time atypical Papanicolaou smear in a young, high-risk African-American and Latino-American population. J Natl Med Assoc. 86:1994;273-277.
39. Noumoff JS. Atypia in cervical cytology as a risk factor for intraepithelial neoplasia. Am J Obstet Gynecol. 156:1987;628-631.
40. Hulka BS. Cytologic and histologic outcome following an atypical cervical smear. Am J Obstet Gynecol. 101:1968;190-199.
41. Pearlstone AC, Grigsby PW, Mutch DG. High rates of atypical cervical cytology Occurrence and clinical significance . Obstet Gynecol. 80:1992;191-195.